The above data show that AMKL patients have a specific immunophenotypic profile, characterized overall by expression of megakaryocyte lineage-associated markers but generally lacking CD13 and HLADR expression. The gene discussed is ANPEP; the disease is acute megakaryoblastic leukemia.